NovaBay (NBY) market analysis | market volatility and institutional inflows remain in focus. NovaBay Pharmaceuticals Inc. (NBY) closed at $1.95, posting a sharp gain of +22.64% on the session. The stock is trading just above the identified support level of $1.85, while the resistance at $2.05 looms as a potential near‑term ceiling for the rally.
NovaBay Pharmaceuticals (NBY) Surges 22.6%: Key Levels to Monitor - Intraday Trade Ideas
NBY - Stock Analysis
3993 Comments
1210 Likes
1
Oweda
Active Reader
2 hours ago
Who else is going through this?
👍 148
Reply
2
Bettsy
Returning User
5 hours ago
Expert US stock analyst coverage consensus and rating distribution analysis to understand market sentiment. We aggregate analyst opinions to provide a consensus view of Wall Street expectations for any stock.
👍 244
Reply
3
Hildana
Consistent User
1 day ago
Free US stock macro sensitivity analysis and sector exposure assessment for economic condition positioning and scenario planning. We help you understand which types of stocks perform best under different economic scenarios and market conditions. We provide sensitivity analysis, exposure assessment, and scenario modeling for comprehensive coverage. Position for conditions with our comprehensive macro sensitivity and exposure analysis tools for strategic asset allocation.
👍 236
Reply
4
Kabao
Senior Contributor
1 day ago
Concise summary, highlights key trends efficiently.
👍 266
Reply
5
Gisell
Active Contributor
2 days ago
Free US stock working capital analysis and operational efficiency metrics to understand business quality and operational effectiveness of portfolio companies. We analyze the efficiency of how companies manage their operations and convert revenue into cash for shareholders. We provide working capital analysis, efficiency metrics, and cash conversion scoring for comprehensive coverage. Understand operational efficiency with our comprehensive working capital analysis and efficiency metrics tools for quality investing.
👍 93
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.